The Microbiotics Company
“ibiotics med” acute care and intensive care creams available in some 600 stores Vienna / Berlin, 15 June 2021 – The microbiotic skincare “ibiotics med”, developed and marketed by BELANO medical AG, will from now on be widely available in Austria. BELANO medical has entered a cooperation with BIPA, Austria’s second-largest drugstore chain. As a first step, the stores will stock the two most
Global marketing of microbiome products expanded Hennigsdorf b. Berlin, 26 May 2021 – BELANO medical AG will expand its health care activities as well as European and global sales and marketing of microbiome-based products. Therefore, the supervisory board decided to expand the company’s management board by a position for marketing and sales, and appointed Alexander Welsch to the board to handle this new responsibility.
R&D collaboration – new brand St. Biomé Düsseldorf / Hennigsdorf b. Berlin, 22 April 2021 – In Henkel Beauty Care, BELANO medical AG gained another major partner for the marketing of its microbiotic skincare. In collaboration with Henkel Beauty Care’s incubator, established in 2020, the company developed the new St. Biomé range of skincare products. Use of the microbiotic agent “stimulans”, developed by BELANO medical,
Argument for natural prophylaxis using neither antibiotics nor antiseptics Hennigsdorf b. Berlin, 15 March 2021 – Inflammation of the gums – referred to as periodontitis or periodontal disease – may negatively affect on and aggravate the course of Covid-19 infections (Coronavirus infections). This said Professor Dr Christine Lang, professor for microbiology at Technical University Berlin and member of BELANO medical AG’s board of directors, in
Collaboration with BELANO medical – articles available in more than 800 stores Ulm / Hennigsdorf b. Berlin, 3 March 2021 – BELANO medical AG and the Müller chain of retail stores step up their collaboration. Under its private label, the chain’s more than 800 outlets offer a number of bio-based, microbiotic, and medical skincare products developed and distributed by BELANO medical. Each article has
State of Brandenburg sponsors BELANO medical’s development of new prophylactic product - Hennigsdorf b. Berlin, 4 February 2021 – Worldwide, there is great clinical demand for nonantibiotic options to target and safely remove pathogenic germs from the skin of patients suffering from atopic eczema patients. Remedies such as antibiotics or antiseptics, which we have so far relied on, are in many cases not indicated, lack